ArticleJournal of computer-aided molecular design2025
Computational characterization and machine learning analysis of quantum optimized marine fungal metabolites targeting PD-L1 in cancer immunotherapy.
Article in Journal of computer-aided molecular design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Cancer immune evasion is predominantly mediated through immune checkpoint pathways, such as the PD-1/PD-L1 axis. In this mechanism, PD-L1, which is often overexpressed on tumor cells, binds to PD-1 receptors on T cells, resulting in the inhibition of T cell activity and allowing tumors to evade immune surveillance. Targeting this interaction is of therapeutic significance. Marine fungal metabolites were investigated as potential PD-L1 inhibitors using a multi-level computational approach that combines quantum chemical, dynamic, energetic, and machine learning studies. Preliminary virtual screening narrowed down the list to the top four contenders, CMNPD20987, CMNPD20986, CMNPD24819, and CMNPD20907, with docking values ranging from - 10.7 to - 8.2 kcal/mol. HOMO-LUMO gap analysis based on the density functional theory demonstrated the highest electronic stability of CMNPD24819 (5.087 eV) and the highest reactivity of CMNPD20907 (3.954 eV). Redocking studies highlighted stable interactions with critical PD-L1 amino acid residues like Tyr
Indexed as
Identifiers
41460593What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.